| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Joseph A Caprini | |
| Mohamed M Eldibany | |||
| P433 | issue | 6 | |
| P921 | main subject | thrombosis | Q261327 |
| P304 | page(s) | 872-884 | |
| P577 | publication date | 2007-06-01 | |
| P1433 | published in | Archives of Pathology & Laboratory Medicine | Q4787305 |
| P1476 | title | Hyperhomocysteinemia and thrombosis: an overview | |
| P478 | volume | 131 |
| Q39176842 | Acute myocardial infarction in a young male wrestler: A case report |
| Q42675054 | Anaesthetic concerns during adrenalectomy for Cushing's syndrome with known hyperhomocysteinemia |
| Q93055213 | Association of Hyperhomocysteinemia with Increased Coronary Microcirculatory Resistance and Poor Short-Term Prognosis of Patients with Acute Myocardial Infarction after Elective Percutaneous Coronary Intervention |
| Q37605879 | Clinical significance of hyperhomocysteinemia in infective endocarditis: A case-control study. |
| Q90470604 | Deep Vein Thrombosis after Femoral Arterial Access: Pathophysiologic and Therapeutic Challenges |
| Q35587037 | Evaluation of a high throughput method for the detection of mutations associated with thrombosis and hereditary hemochromatosis in Brazilian blood donors |
| Q36075584 | Evaluation of oxidative stress markers and cardiovascular risk factors in Fabry Disease patients |
| Q37398046 | Factor V Leiden and thrombosis in patients with systemic lupus erythematosus: a meta-analysis |
| Q33851777 | Genetic Variants Involved in One-Carbon Metabolism: Polymorphism Frequencies and Differences in Homocysteine Concentrations in the Folic Acid Fortification Era |
| Q36807470 | Genetic risk factors for thrombosis in systemic lupus erythematosus |
| Q35263482 | Hereditary thrombophilic risk factors for recurrent pregnancy loss. |
| Q34144981 | Homocysteine and its relationship to deep venous thrombosis in patients undergoing total knee or hip arthroplasty |
| Q42595647 | Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis |
| Q37231486 | Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk |
| Q33875897 | Hypercoagulable states: an algorithmic approach to laboratory testing and update on monitoring of direct oral anticoagulants |
| Q38255869 | Hyperhomocysteinemia: Anesthetic concerns |
| Q38178063 | Inherited risk factors for venous thromboembolism |
| Q37407728 | Laboratory informatics based evaluation of methylene tetrahydrofolate reductase C677T genetic test overutilization |
| Q38821457 | MTHFR: Addressing Genetic Counseling Dilemmas Using Evidence-Based Literature |
| Q37567658 | Meta-analysis of Factor V Leiden G1691A polymorphism and osteonecrosis of femoral head susceptibility |
| Q79717867 | Non-arteritic anterior ischemic optic neuropathy and thrombophilia |
| Q36153982 | Patients with chronic three-vessel disease in a 15-year follow-up study: genetic and non-genetic predictors of survival |
| Q35153882 | Pheochromocytoma presenting with arterial and intracardiac thrombus in a 47-year-old woman: a case report |
| Q85749590 | Prevalence of variants in methylenetetrahydrofolate reductase and the severity of pulmonary vascular disease |
| Q90602259 | Simultaneous pulmonary thromboembolism and superior mesenteric venous thrombosis associated with hyperhomocysteinemia secondary to pernicious anemia-induced vitamin B12 deficiency |
| Q35673950 | The 844ins68 cystathionine beta-synthase and C677T MTHFR gene polymorphism and the vaso-occlusive event risk in sickle cell disease |
| Q38250442 | The role of hemostasis in infective endocarditis |
| Q37630461 | Transsulfuration Is a Significant Source of Sulfur for Glutathione Production in Human Mammary Epithelial Cells |
| Q50216654 | Unrecognized cobalamin deficiency, nitrous oxide, and reversible subacute combined degeneration. |
| Q53142866 | Variant alleles in factor V, prothrombin, plasminogen activator inhibitor-1, methylenetetrahydrofolate reductase and risk of thromboembolism in metastatic colorectal cancer patients treated with first-line chemotherapy plus bevacizumab. |
| Q50103957 | Venous Thromboembolism During Treatment with Antipsychotics: A Review of Current Evidence |
| Q38021516 | Venous thromboembolism in recipients of antipsychotics: incidence, mechanisms and management |
Search more.